Mike Webster
Senior Vice President, Commercial
Expertise:
Mike is a senior vice president, commercial at EVERSANA. Mike is recognized by peers and competitors for excellence in the life sciences industry for strategic marketing, business development and team leadership.. Mike has deep experience building initiatives from the ground up, starting with a vision and mission.
Mike is a founding partner of The Access Group, an award winning market access healthcare communications agency. Mike’s company was acquired by EVERSANA in 2017. Prior to joining The Access Group, Mike spent 13 years at Schering-Plough Pharmaceuticals, primarily in the areas of marketing and market access. During his tenure at Schering, Mike held a leadership position on the Claritin® marketing team, a multibillion dollar brand. In this role, he led the managed care marketing efforts and developed the strategic value proposition and assets to support the launch of Claritin to payers. In his role, Mike established the first in market strategic outreach and reimbursement campaign for a pharmaceutical product to Fortune 500 employers.
Mike is a member of The International Foundation of Employee Benefit Plans (IFEBP) and is a corporate member of The Academy of Managed Care Pharmacy (AMCP). Mike holds a bachelor of science degree in biology from Montclair State University in New Jersey.
Articles by Mike Webster
Balancing the Portfolio: How Extending Mature Brands’ Success Can Replenish Costs Invested In Launching New Products
The traditional mindset toward established brands in the pharmaceutical industry has largely been to let focus fade from them and shift entirely to developing and launching new products. With emphasis placed almost exclusively on new product launches, mature brands are essentially starved of any resources to keep them healthy and vital, even if they are still generating hundreds of millions of dollars in revenue. Declaring mature brands lifeless well before their time is one of the most common mistakes manufacturers make. While a decline in revenue is inevitable for established brands as loss of exclusivity (LOE) approaches, incremental investments can greatly decrease that decline and yield significant returns. Companies should […]
Asset Optimization: Breathe New Life Into Mature Brands with EVERSANA REIGNITE™
Maximizing revenue potential throughout products’ entire lifecycles before they reach loss of exclusivity (LOE) is the most impactful return on investment manufacturers can make for their established brands. While many companies figuratively put their mature brands out to pasture to invest more in new products, they ignore the significant revenue still to be gained from a loyal base of patients, physician advocates and overall brand awareness. These products tend to be highly promotionally responsive at this point in their lifecycle, and their revenue can be leveraged to replenish investments into new brands that often take years to see prosperity. By looking at asset optimization across different confounding variables, achieving ample […]